X0304 4 2011-11-16 0 0001466301 Clovis Oncology, Inc. CLVS 0001456590 Versant Venture Capital IV, L.P. 3000 SAND HILL ROAD BLDG 4, SUITE 210 MENLO PARK CA 94025 0 0 1 0 0001456591 Versant Side Fund IV, L.P. 3000 SAND HILL ROAD BLDG 4, SUITE 210 MENLO PARK CA 94025 0 0 1 0 0001456589 Versant Ventures IV, LLC 3000 SAND HILL ROAD BLDG 4, SUITE 210 MENLO PARK CA 94025 0 0 1 0 Common Stock 2011-11-16 4 P 0 661323 0 A 2159289 I See Footnote Common Stock 2011-11-16 4 P 0 4165 0 A 13600 I See Footnote Series A-1 Convertible Preferred Stock 2011-11-16 4 C 0 295404 0 A Common Stock 295404 0 I See Footnote Series A-1 Convertible Preferred Stock 2011-11-16 4 C 0 1861 0 A Common Stock 1861 0 I See Footnote Series A-2 Convertible Preferred Stock 2011-11-16 4 C 0 295404 0 A Common Stock 295404 0 I See Footnote Series A-2 Convertible Preferred Stock 2011-11-16 4 C 0 1861 0 A Common Stock 1861 0 I See Footnote Series B Convertible Preferred Stock 2011-11-16 4 C 0 639403 0 A Common Stock 639403 0 I See Footnote Series B Convertible Preferred Stock 2011-11-16 4 C 0 4027 0 A Common Stock 4027 0 I See Footnote Convertible Promissory Note 2011-11-16 4 C 0 267755 0 A Common Stock 267755 0 I See Footnote Convertible Promissory Note 2011-11-16 4 C 0 1686 0 A Common Stock 1686 0 I See Footnote Each share of Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock on a 1 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date Each share of Series A-2 Convertible Preferred Stock automatically converted into shares of Common Stock on a 1 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date Each share of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 1 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. The outstanding principal amount and all accrued and unpaid interest automatically converted into Common Stock at a rate of $13.00 per share, which was the Company's initial public offering price. The shares are held by Versant Venture Capital IV, L.P. ("Versant IV"). In their capacity as managing members of Versant Ventures IV, LLC which is the general partner of Versant IV, Brian G. Atwood, Ross A. Jaffe, M.D., Camille D. Samuels, Kevin J. Wasserstein, Samuel D. Colella, Rebecca B. Robertson, Bradley J. Bolzon, Ph.D., William J. Link, Ph.D., Charles M. Warden, Robin L. Praeger and Kirk G. Nielsen share voting and investment authority over the shares held by the Versant IV and may be deemed to beneficially own the shares. Each of Brian G. Atwood, Ross A. Jaffe, M.D., Camille D. Samuels, Kevin J. Wasserstein, Samuel D. Colella, Rebecca B. Robertson, Bradley J. Bolzon, Ph.D., William J. Link, Ph.D., Charles M. Warden, Robin L. Praeger and Kirk G. Nielsen disclaim beneficial ownership of these shares except to the extent of his or her pecuniary interest therein. The shares are held by Versant Side Fund IV, L.P. ("Versant Side"). In their capacity as managing members of Versant Ventures IV, LLC which is the general partner of Versant Side, Brian G. Atwood, Ross A. Jaffe, M.D., Camille D. Samuels, Kevin J. Wasserstein, Samuel D. Colella, Rebecca B. Robertson, Bradley J. Bolzon, Ph.D., William J. Link, Ph.D., Charles M. Warden, Robin L. Praeger and Kirk G. Nielsen share voting and investment authority over the shares held by the Versant Side and may be deemed to beneficially own the shares. Each of Brian G. Atwood, Ross A. Jaffe, M.D., Camille D. Samuels, Kevin J. Wasserstein, Samuel D. Colella, Rebecca B. Robertson, Bradley J. Bolzon, Ph.D., William J. Link, Ph.D., Charles M. Warden, Robin L. Praeger and Kirk G. Nielsen disclaim beneficial ownership of these shares except to the extent of his or her pecuniary interest therein. VERSANT VENTURE CAPITAL IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Robin L. Praeger, as Attorney-In-Fact 2011-11-17 VERSANT SIDE FUND IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Robin L. Praeger, as Attorney-In-Fact 2011-11-17 VERSANT VENTURES IV, LLC By: Robin L. Praeger, as Attorney-In-Fact 2011-11-17